Key facts
- Deep Blue’s last known valuation is $22.0M (Sep 2025).
- It has raised $17.9M; the latest was Later Stage VC ($5.3M) in Sep 2025.
- Notable investors include US National Science Foundation, Band of Angels, Duke Capital Partners, SeedFolio, Triangle Angel Partners — 20 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 20 names
- ·Watchlist + deal alerts for Deep Blue
- ·The full record, as it builds
Funding rounds
No funding rounds for Deep Blue are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Deep Blue
Developer of surgical textile implants designed to reduce the occurrence and recurrence of abdominal wall defects. The company offers a monofilament polypropylene mesh featuring integrated extensions that distribute tension across a larger surface area while eliminating the need for traditional fixation methods, enabling surgeons and medical facilities to improve patient outcomes through increased anchoring strength and reduced tissue stress at the operative site.
- Sector
- Healthcare
- HQ
- Durham, NC, United States
- Founded
- 2015
- Employees
- 10
- Website
- deepbluemedical.com/
- Ownership
- Privately Held (backing)
Deep Blue doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Deep Blue shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Deep Blue in its N-PORT filings yet. We sweep new filings monthly.